Prévôt Thomas D, Gastambide François, Viollet Cécile, Henkous Nadia, Martel Guillaume, Epelbaum Jacques, Béracochéa Daniel, Guillou Jean-Louis
Institut de Neurosciences Cognitives et Intégratives d'Aquitaine, Avenue des Facultés, Université de Bordeaux, Talence cedex, France.
Centre National de la Recherche Scientifique, UMR 5287, Institut de Neurosciences Cognitives et Intégratives d'Aquitaine, Avenue des Facultés, Talence cedex, France.
Neuropsychopharmacology. 2017 Jul;42(8):1647-1656. doi: 10.1038/npp.2016.281. Epub 2016 Dec 16.
Altered brain somatostatin functions recently appeared as key elements for the pathogenesis of stress-related neuropsychiatric disorders. The hippocampus exerts an inhibitory feedback on stress but the mechanisms involved remain unclear. We investigated herein the role of hippocampal somatostatin receptor subtypes in both stress response and behavioral emotionality using C57BL/6, wild type and sst or sst knockout mice. Inhibitory effects of hippocampal infusions of somatostatin agonists on stress-induced hypothalamo-pituitary-adrenal axis (HPA) activity were tested by monitoring peripheral blood and local hippocampus corticosterone levels, the latter by using microdialysis. Anxiolytic and antidepressant-like effects were determined in the elevated-plus maze, open field, forced swimming, and stress-sensitive beam walking tests. Hippocampal injections of somatostatin analogs and sst or sst but not sst or sst receptor agonists produced rapid and sustained inhibition of HPA axis. sst agonists selectively produced anxiolytic-like behaviors whereas both sst and sst agonists had antidepressant-like effects. Consistent with these findings, high corticosterone levels and anxiety were found in sstKO mice and depressive-like behaviors observed in both sstKO and sstKO strains. Both hippocampal sst and sst receptors selectively inhibit stress-induced HPA axis activation but mediate anxiolytic and antidepressive effects through distinct mechanisms. Such results are to be accounted for in development of pathway-specific somatostatin receptor agents in the treatment of hypercortisolism (Cushing's disease) and stress-related neuropsychiatric disorders.
脑内生长抑素功能改变最近被认为是应激相关神经精神障碍发病机制的关键因素。海马体对压力发挥抑制性反馈作用,但其涉及的机制仍不清楚。我们在此使用C57BL/6野生型小鼠以及生长抑素1型受体(sst1)或生长抑素2型受体(sst2)基因敲除小鼠,研究海马体生长抑素受体亚型在应激反应和行为情绪方面的作用。通过监测外周血和局部海马体中的皮质酮水平(后者使用微透析法),测试海马体注射生长抑素激动剂对压力诱导的下丘脑-垂体-肾上腺轴(HPA轴)活性的抑制作用。在高架十字迷宫、旷场、强迫游泳和应激敏感横梁行走试验中测定抗焦虑和抗抑郁样作用。海马体注射生长抑素类似物以及sst1或sst2但不是sst3或sst4受体激动剂可快速且持续地抑制HPA轴。sst2激动剂选择性地产生抗焦虑样行为,而sst1和sst2激动剂均具有抗抑郁样作用。与这些发现一致,在sst1基因敲除小鼠中发现高皮质酮水平和焦虑,在sst1基因敲除和sst2基因敲除品系中均观察到抑郁样行为。海马体中的sst1和sst2受体均选择性地抑制应激诱导的HPA轴激活,但通过不同机制介导抗焦虑和抗抑郁作用。在开发针对高皮质醇血症(库欣病)和应激相关神经精神障碍的通路特异性生长抑素受体药物时,应考虑这些结果。